Related Experiment Video
Updated: Jul 18, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Vitamin C neglect in hemodialysis: sailing between Scylla and Charybdis
1Renal Research Institute, 207 E. 94th Street, New York, NY 10128, USA. ghandelman@rriny.com
Insights
Dialysis patients face a dilemma regarding vitamin C supplementation. Current evidence suggests vitamin C therapy is safe and beneficial for managing anemia in dialysis patients, resolving concerns about oxalosis.
Area of Science:
- Nephrology
- Nutritional Science
- Clinical Medicine
Background:
- Dialysis patients often experience vitamin C deficiency, leading to complications like anemia, fatigue, and poor oral health.
- A historical concern regarding vitamin C supplementation in dialysis patients was the risk of oxalosis, a condition caused by excess oxalic acid.
- Emerging evidence suggests vitamin C may improve anemia management in dialysis patients, necessitating a re-evaluation of its safety and efficacy.
Purpose of the Study:
- To address the medical dilemma of vitamin C supplementation in dialysis patients, balancing the risks of deficiency against potential toxicity.
- To investigate the safety and effectiveness of vitamin C therapy in dialysis patients, particularly concerning the risk of oxalosis.
- To reconcile conflicting views on vitamin C use in dialysis by examining current evidence and guiding future research.
Main Methods:
- Review of accumulating evidence regarding vitamin C supplementation in dialysis patients.
- Analysis of historical data and current clinical observations related to vitamin C therapy and oxalosis.
- Identification of the need for controlled trials to definitively assess vitamin C's effectiveness and safety.
Main Results:
- Vitamin C deficiency in dialysis patients is associated with significant health consequences, including hematological issues and chronic fatigue.
- Concerns about oxalosis stemming from vitamin C supplements are largely based on outdated hemodialysis practices.
- Current data indicate that vitamin C therapy is safe for dialysis patients, with no observed systemic oxalosis in contemporary investigations.
Conclusions:
- The perceived risk of oxalosis from vitamin C supplementation in dialysis patients may be overstated based on historical data.
- Vitamin C therapy appears safe and potentially beneficial for dialysis patients, particularly in managing anemia.
- Further controlled trials are essential to conclusively determine the optimal use of vitamin C for both effectiveness and safety in dialysis patients.
Abstract:
In our efforts to meet the vitamin C requirements of dialysis patients we confront a medical dilemma--do we allow the patient to become depleted of vitamin C, with the accompanying hematological and other consequences (Scylla), or do we provide for adequate tissue levels of vitamin C, which has been thought to carry the risk of oxalosis (Charybdis). Many practitioners are certain that either one outcome (deficiency) or the other (oxalic acid toxicity) is inevitable, and much like Odysseus, no safe course is to be found. The recent accumulating evidence that vitamin C improves the management of anemia in dialysis patients compels us to find a safe passage through this dilemma. The serious vitamin C deficiency seen in many patients may also contribute to poor oral health and chronic fatigue. The evidence for oxalosis from vitamin C supplements stems from hemodialysis as practiced 20 years ago. Investigators using this therapy are not observing systemic oxalosis, and the most current data support the conclusion that vitamin C therapy is safe for dialysis patients. The question will be resolved by controlled trials that address both vitamin C effectiveness and safety.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Vitamins
Hemodialysis I: Introduction
Dialysis
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
